Streetbeat News

Partnerships

TCBP

TC BioPharm (Holdings) PLC (NASDAQ:TCBP), a clinical stage biotechnology company, announced significant operational achievements including FDA clearance for a Phase 1B study in AML, a new collaboration with Queen Mary University of London, and cost-savings of approximately $11.6M. The company successfully dosed the final patient in the ACHIEVE Study safety cohort and looks forward to interim data in 2024. TCBP also highlighted its focus on strategic partnerships and platform expansion into anti-fungal and anti-bacterial programs.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:46 pm

IPX

IperionX is advancing towards commercial-scale titanium production with significant progress at its Virginia Titanium Manufacturing Campus. The company has received the first $2.4M from a $12.7M Department of Defense grant for the Phase I ramp-up. The HAMR titanium furnace, a key asset, has passed factory tests and is expected to be installed in Q2 2024, with titanium production starting mid-year. This initiative aims to revitalize the U.S. titanium supply chain, offering high-performance, low-cost titanium products with lower environmental impacts.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:44 pm

EMN

Eastman has entered into a long-term agreement with Nord Pal Plast, part of the Dentis Group, to supply 30,000 metric tons of product per year. This deal signifies a significant commitment between Eastman and Nord Pal Plast and may influence Eastman's production volume and revenue.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:40 pm

AAPL

GOOG

META

Apple Inc. has launched Keyframer, a generative AI tool that animates static images using text prompts. This innovation, part of Apple's expanding AI portfolio, leverages large language models to generate animations from SVG images. Keyframer's development was informed by professional animators and allows for iterative design refinement. This move is in line with Apple's recent AI advancements, including an AI image editing tool and the acquisition of the iWork.ai domain, indicating a strategic push into AI to compete with rivals like Google and Meta Platforms.

Portfolio Pulse from Rounak Jain

February 14, 2024 | 1:39 pm

OPTT

Ocean Power Technologies (OPTT) has been awarded funding by the Naval Postgraduate School for a year-long deployment of its PowerBuoy technology in Monterey Bay. This initiative aims to demonstrate the capabilities and reliability of the PowerBuoy system in a real-world setting.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:19 pm

OTLK

Outlook Therapeutics announced the formal review process for ONS-5010 by the EMA's Committee for Medicinal Products for Human Use, with a decision expected in H1 2024. The company is also exploring an expanded relationship with Cencora, has begun NORSE EIGHT with the first subject dosed, and plans to resubmit the ONS-5010 BLA by the end of CY2024.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:17 pm

GSK

GSK has exercised its option to license Elsie Biotechnologies' discovery platform for finding and developing novel oligonucleotides. This strategic move aims to enhance GSK's capabilities in discovering and developing new therapeutic oligonucleotides, which are short DNA or RNA molecules that can regulate gene expression.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:15 pm

IMMR

META

Immersion Corporation has entered into a licensing agreement with Meta Platforms, granting Meta and its affiliates access to Immersion's patents. These patents will be utilized across Meta's hardware, software, virtual reality (VR), and gaming products.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:09 pm

QUBT

Quantum Computing Inc. has been awarded a fourth subcontract from NASA, marking another significant milestone in its collaboration with the space agency. This development underscores the company's growing influence and expertise in the field of quantum computing, a sector that is increasingly recognized for its potential to revolutionize various industries, including space exploration.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:08 pm

VSTE

Vast Renewables Limited (Vast) and Mabanaft have secured up to AUD $40 million in funding for the SM1 solar methanol plant, aimed at decarbonizing shipping by producing green methanol using concentrated solar thermal power (CSP) technology. The funding, provided by the Australian Renewable Energy Agency (ARENA) and Projektträger Jülich (PtJ) on behalf of the German government, supports the German-Australian Hydrogen Innovation and Technology Incubator (HyGATE) program. SM1, powered by Vast's CSP v3.0 technology, aims to produce up to 7,500 tonnes of green methanol annually, potentially reducing green fuel production costs by up to 40% and creating hundreds of jobs.

Portfolio Pulse from Benzinga Newsdesk

February 14, 2024 | 1:04 pm